Jou‐Wei Lin

831 citations
27 papers · 584 indexed · h-index 15
Topics
Cardiovascular Function and Risk Factors (5 papers)Heart Failure Treatment and Management (5 papers)Liver Disease Diagnosis and Treatment (4 papers)
Partner nations
TaiwanUnited States

In The Last Decade

Jou‐Wei Lin

26 papers receiving 575 citations

Peers

Jou‐Wei Lin
Comparison fields: 5 of 99
  • Cardiology and Cardiovascular Medicine 213
  • Epidemiology 103
  • Surgery 102
  • Molecular Biology 77
  • Pharmacology 75
Replace Shin‐Yi Lin with:
Shin‐Yi Lin Taiwan
Elizabeth K. Weidman United States
M Yamane Japan
Jin‐Shang Wu Taiwan
Mohit Gupta India
Colin Church United Kingdom
Santhosh Satheesh India
Kenan Yalta Türkiye
Yasuhiro Matsubayashi Japan
Yulong Chen China
Jou‐Wei Lin relative to Shin‐Yi Lin Taiwan Shin‐Yi Lin's profile →
Citations per field
00.5×3.6×
Shin‐Yi Lin · 1×
Citations per year

Countries citing papers authored by Jou‐Wei Lin

Since Specialization
Citations

This map shows the geographic impact of Jou‐Wei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jou‐Wei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jou‐Wei Lin more than expected).

Fields of papers citing papers by Jou‐Wei Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jou‐Wei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jou‐Wei Lin. The network helps show where Jou‐Wei Lin may publish in the future.

Co-authorship network of co-authors of Jou‐Wei Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Jou‐Wei Lin. A scholar is included among the top collaborators of Jou‐Wei Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jou‐Wei Lin. Jou‐Wei Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 45
3 5
4 1
5 9
6 7
7 56
8 6
9 57
10 4
11 27
12 21
13 37
14 16
15 51
16 28
17 14
18 5
19 5
20 50

About Jou‐Wei Lin

Jou‐Wei Lin is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism, having authored 27 papers that have together received 584 indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (5 papers), Heart Failure Treatment and Management (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (213 citations), Nephrology (43 citations) and Pharmacology (75 citations). Jou‐Wei Lin has collaborated with scholars based in Taiwan and United States. Frequent co-authors include Juey‐Jen Hwang, Steven R. Bergmann, Andrew F. Laine, Chia‐Hsuin Chang, Karen A. Thomas, Lu‐Ting Kuo, Shao‐Yu Tsai, Fu‐Tien Chiang, Jiunn-Lee Lin and Chia‐Ti Tsai. Their work appears in journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Gut.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026